Intracranial responses with selective KRAS-G12C inhibitors in non-small cell lung cancer

被引:1
|
作者
Lu, Kevin [1 ]
Husain, Hatim [1 ,2 ]
机构
[1] Univ Calif San Diego, La Jolla, CA USA
[2] Univ Calif San Diego, Div Med Oncol, 3855 Hlth Sci 3011, La Jolla, CA 92093 USA
关键词
Non-small cell lung cancer (NSCLC); KRAS G12C; adagrasib; sotorasib; BRAIN METASTASES; NSCLC;
D O I
10.21037/tlcr-23-26
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1335 / 1337
页数:3
相关论文
共 50 条
  • [41] KRAS G12C-Mutant Non-Small Cell Lung Cancer Biology, Developmental Therapeutics, and Molecular Testing
    Veluswamy, Rajwanth
    Mack, Philip C.
    Houldsworth, Jane
    Elkhouly, Ehab
    Hirsch, Fred R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2021, 23 (05): : 507 - 520
  • [42] Treatment Outcomes and Clinical Characteristics of Patients with KRAS-G12C-Mutant Non-Small Cell Lung Cancer
    Arbour, Kathryn C.
    Rizvi, Hira
    Plodkowski, Andrew J.
    Hellmann, Matthew D.
    Knezevic, Andrea
    Heller, Glenn
    Yu, Helena A.
    Ladanyi, Marc
    Kris, Mark G.
    Arcila, Maria E.
    Rudin, Charles M.
    Lito, Piro
    Riely, Gregory J.
    CLINICAL CANCER RESEARCH, 2021, 27 (08) : 2209 - 2215
  • [43] Correction to: Sotorasib: A Review in KRAS G12C Mutation-Positive Non-small Cell Lung Cancer
    Arnold Lee
    Targeted Oncology, 2023, 18 : 177 - 177
  • [44] KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer
    Park, Sehhoon
    Kim, Ji-Yeon
    Lee, Se-Hoon
    Suh, Beomseok
    Keam, Bhumsuk
    Kim, Tae Min
    Kim, Dong-Wan
    Heo, Dae Seog
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (03): : 514 - 522
  • [45] Prevalence of KRAS p.G12C mutation in patients with metastatic non-small cell lung cancer in Argentina
    Mendoza Bertelli, Andrea
    Otero Pizarro, Maria Mercedes
    Fernandez, Maria Paz
    Dibarbora, Delfina
    Florencia Cantarella, Maria
    Damian Mahmoud, Yamil
    Girotti, Romina
    Guttlein, Leandro
    Chico, Isagani
    Brandalise, Patricia
    Dutra, Carolina
    Salanova, Ruben
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [46] Combination therapy of adagrasib and abemaciclib in non-small cell lung cancer brain metastasis models genomically characterized by KRAS-G12C and homozygous loss of CDKN2A
    Christian Migliarese
    Yinon Sadeh
    Consuelo Torrini
    Fatma Turna Demir
    Naema Nayyar
    Erika Yamazawa
    Yuu Ishikawa
    Nazanin Ijad
    Elizabeth J. Summers
    Adam Elliott
    Lisa Rahbaek
    Barbara Saechao
    Jill Hallin
    Priscilla K. Brastianos
    Hiroaki Wakimoto
    Acta Neuropathologica Communications, 13 (1)
  • [47] The MET Inhibitor Tepotinib Potentially Inhibits KRAS G12C and SHOC2 in KRAS G12C Non-Small Cell Lung Cancer (NSCLC)
    Rosell, R.
    Jain, A.
    Codony-Servat, J.
    Shivamallu, C.
    Kollur, S. Prasad
    Prasad, A.
    Jantus-Lewintre, E.
    Ito, M.
    Cardona, A. F.
    Arrieta, O.
    Cao, P.
    Cai, X.
    Xing, B.
    Pedraz-Valdunciel, C.
    Dantes, Z.
    Sullivan, I.
    Aguilar, A.
    Molina-Vila, M. A.
    Gonzalez-Cao, M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S112 - S112
  • [48] Targeting KRAS in Non-Small Cell Lung Cancer
    Corral de la Fuente, Elena
    Olmedo Garcia, Maria Eugenia
    Gomez Rueda, Ana
    Lage, Yolanda
    Garrido, Pilar
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [49] KRAS G12C vs. non-G12C non-small cell lung cancer (NSCLC): Insights from gene expression analysis
    Pinto, L. Masfarre
    Clave, S.
    Sanchez, I.
    Perera-Bel, J.
    Berenguer-Molins, P.
    Bodalo-Torruella, M.
    Navarro-Gorro, N.
    Miquel, C.
    Torres, E.
    Garcia, A. Taus
    Del Rey-Vergara, R.
    Paricio, B. Bellosillo
    Da Rocha, P. F. Simoes
    Aperribay, E. Arriola
    JOURNAL OF THORACIC ONCOLOGY, 2025, 20 (03)
  • [50] Characteristics and treatment outcomes in advanced stage non-small cell lung cancer patients with KRAS G12C mutation
    Illini, Oliver
    Fabikan, Hannah
    Hochmair, Maximilian J.
    Weinlinger, Christoph
    Krenbek, Dagmar
    Brcic, Luka
    Setinek, Ulrike
    Terbuch, Angelika
    Absenger, Gudrun
    Konji, Selma
    Valipour, Arschang
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (19-20) : 727 - 728